{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:52:32Z","timestamp":1767142352001,"version":"build-2238731810"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12035-025-05185-w","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T06:02:40Z","timestamp":1752645760000},"page":"14156-14166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the Predictive Value of Oxylipins for Cognitive Measures\u00a0and White Matter Hyperintensities in Alzheimer\u2019s Disease Continuum\u00a0Compared to Conventional Beta\u2011amyloid and Tau Protein Biomarkers"],"prefix":"10.1007","volume":"62","author":[{"given":"Alireza","family":"Shaabanpoor Haghighi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Mayeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Ramezannezhad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negin","family":"Pouroushaninia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rezvan","family":"Barzegar Parizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahtab","family":"Nourollahi-Foumeshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasim","family":"Idelkhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Dadjou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niloofar","family":"Saeedipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negar","family":"Safaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Homa","family":"Partoandaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahan","family":"Shafie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjan","family":"Falahati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"issue":"4","key":"5185_CR1","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3233\/JAD-170810","volume":"61","author":"C-C Yang","year":"2018","unstructured":"Yang C-C, Chiu M-J, Chen T-F, Chang H-L, Liu B-H, Yang S-Y (2018) Assay of plasma phosphorylated tau protein (threonine 181) and total tau protein in early-stage Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 61(4):1323\u20131332","journal-title":"J Alzheimer\u2019s Dis"},{"key":"5185_CR2","unstructured":"Alzheimers A (2015) Alzheimer\u2019s disease facts and figures, Alzheimer\u2019s dement. J Alzheimer\u2019s Assoc 11(3)"},{"issue":"1","key":"5185_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-022-00296-z","volume":"11","author":"TO Klyucherev","year":"2022","unstructured":"Klyucherev TO, Olszewski P, Shalimova AA, Chubarev VN, Tarasov VV, Attwood MM et al (2022) Advances in the development of new biomarkers for Alzheimer\u2019s disease. Transl Neurodegen 11(1):1\u201324","journal-title":"Transl Neurodegen"},{"issue":"14","key":"5185_CR4","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2174\/1567205015666181004143432","volume":"15","author":"T Hamano","year":"2018","unstructured":"Hamano T, Hayashi K, Shirafuji N, Nakamoto Y (2018) The implications of autophagy in Alzheimer\u2019s disease. Curr Alzheimer Res 15(14):1283\u20131296","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"5185_CR5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jalz.2018.03.002","volume":"14","author":"D Knopman","year":"2018","unstructured":"Knopman D, Haeberlein S, Carrillo M, Hendrix J, Kerchner G, Margolin R et al (2018) The national institute on aging and the Alzheimer\u2019s association research framework for Alzheimer\u2019s disease: perspectives from the research roundtable. Alzheimer\u2019s Dement 14(4):563\u201375","journal-title":"Alzheimer\u2019s Dement"},{"issue":"11","key":"5185_CR6","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","volume":"14","author":"O Hansson","year":"2018","unstructured":"Hansson O, Seibyl J, Stomrud E, Zetterberg H, Trojanowski JQ, Bittner T et al (2018) CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-\u03b2 PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts. Alzheimer\u2019s Dementia 14(11):1470\u20131481","journal-title":"Alzheimer\u2019s Dementia"},{"key":"5185_CR7","doi-asserted-by":"crossref","unstructured":"Palmqvist S, Tideman P, Cullen N, Zetterberg H, Blennow K, Initiative AsDN, et al (2021) Prediction of future Alzheimer\u2019s disease dementia using plasma phospho-tau combined with other accessible measures. Nat Med 27(6):1034\u201342.","DOI":"10.1038\/s41591-021-01348-z"},{"issue":"3","key":"5185_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","volume":"26","author":"S Janelidze","year":"2020","unstructured":"Janelidze S, Mattsson N, Palmqvist S, Smith R, Beach TG, Serrano GE et al (2020) Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia. Nat Med 26(3):379\u2013386","journal-title":"Nat Med"},{"issue":"1\u20132","key":"5185_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jns.2012.07.032","volume":"322","author":"RN Kalaria","year":"2012","unstructured":"Kalaria RN, Akinyemi R, Ihara M (2012) Does vascular pathology contribute to Alzheimer changes? J Neurol Sci 322(1\u20132):141\u2013147","journal-title":"J Neurol Sci"},{"key":"5185_CR10","doi-asserted-by":"publisher","first-page":"103383","DOI":"10.1016\/j.nicl.2023.103383","volume":"38","author":"SL Alban","year":"2023","unstructured":"Alban SL, Lynch KM, Ringman JM, Toga AW, Chui HC, Sepehrband F et al (2023) The association between white matter hyperintensities and amyloid and tau deposition. NeuroImage Clin 38:103383","journal-title":"NeuroImage Clin"},{"key":"5185_CR11","first-page":"18","volume":"4","author":"BM Kandel","year":"2016","unstructured":"Kandel BM, Avants BB, Gee JC, McMillan CT, Erus G, Doshi J et al (2016) White matter hyperintensities are more highly associated with preclinical Alzheimer\u2019s disease than imaging and cognitive markers of neurodegeneration. Alzheimer\u2019s Dement Diagn Assess Dis Monit 4:18\u201327","journal-title":"Alzheimer\u2019s Dement Diagn Assess Dis Monit"},{"issue":"8","key":"5185_CR12","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R et al (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12(8):822\u2013838","journal-title":"Lancet Neurol"},{"issue":"8","key":"5185_CR13","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1002\/alz.13057","volume":"19","author":"A Garnier-Crussard","year":"2023","unstructured":"Garnier-Crussard A, Cotton F, Krolak-Salmon P, Ch\u00e9telat G (2023) White matter hyperintensities in Alzheimer\u2019s disease: beyond vascular contribution. Alzheimer\u2019s Dement 19(8):3738\u20133748","journal-title":"Alzheimer\u2019s Dement"},{"issue":"3","key":"5185_CR14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/alz.12410","volume":"18","author":"A Garnier-Crussard","year":"2022","unstructured":"Garnier-Crussard A, Bougacha S, Wirth M, Dautricourt S, Sherif S, Landeau B et al (2022) White matter hyperintensity topography in Alzheimer\u2019s disease and links to cognition. Alzheimer\u2019s Dement 18(3):422\u2013433","journal-title":"Alzheimer\u2019s Dement"},{"issue":"5","key":"5185_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3945\/an.114.007732","volume":"6","author":"M Gabbs","year":"2015","unstructured":"Gabbs M, Leng S, Devassy JG, Monirujjaman M, Aukema HM (2015) Advances in our understanding of oxylipins derived from dietary PUFAs. Adv Nutr 6(5):513\u2013540","journal-title":"Adv Nutr"},{"key":"5185_CR16","doi-asserted-by":"publisher","first-page":"117065","DOI":"10.1016\/j.trac.2023.117065","volume":"164","author":"SM Camunas-Alberca","year":"2023","unstructured":"Camunas-Alberca SM, Moran-Garrido M, S\u00e1iz J, Villase\u00f1or A, Taha AY, Barbas C (2023) The role of oxylipins and their validation as biomarkers in the clinical context. TrAC Trends Anal Chem 164:117065","journal-title":"TrAC Trends Anal Chem"},{"issue":"12","key":"5185_CR17","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3390\/metabo12121238","volume":"12","author":"M Misheva","year":"2022","unstructured":"Misheva M, Johnson J, McCullagh J (2022) Role of oxylipins in the inflammatory-related diseases NAFLD, obesity, and type 2 diabetes. Metabolites 12(12):1238","journal-title":"Metabolites"},{"issue":"6","key":"5185_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.plaphy.2008.12.011","volume":"47","author":"A Mosblech","year":"2009","unstructured":"Mosblech A, Feussner I, Heilmann I (2009) Oxylipins: structurally diverse metabolites from fatty acid oxidation. Plant Physiol Biochem 47(6):511\u2013517","journal-title":"Plant Physiol Biochem"},{"issue":"6","key":"5185_CR19","first-page":"6","volume":"89","author":"VA Shipelin","year":"2020","unstructured":"Shipelin VA, Sidorova YS (2020) Oxylipins-biologically active substances of food. Vopr Pitan 89(6):6\u201313","journal-title":"Vopr Pitan"},{"issue":"7","key":"5185_CR20","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/aps.2018.24","volume":"39","author":"MA Nayeem","year":"2018","unstructured":"Nayeem MA (2018) Role of oxylipins in cardiovascular diseases. Acta Pharmacol Sin 39(7):1142\u20131154","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"5185_CR21","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3390\/metabo12090826","volume":"12","author":"LH Shinto","year":"2022","unstructured":"Shinto LH, Raber J, Mishra A, Roese N, Silbert LC (2022) A review of oxylipins in Alzheimer\u2019s disease and related dementias (ADRD): potential therapeutic targets for the modulation of vascular tone and inflammation. Metabolites 12(9):826","journal-title":"Metabolites"},{"key":"5185_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11306-017-1249-0","volume":"13","author":"J Fang","year":"2017","unstructured":"Fang J, Cui L, Sun Y, Feng L, Ong CN (2017) Targeted metabolomics reveals altered oxylipin profiles in plasma of mild cognitive impairment patients. Metabolomics 13:1\u20138","journal-title":"Metabolomics"},{"issue":"16","key":"5185_CR23","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.3390\/app14167001","volume":"14","author":"D Mattie","year":"2024","unstructured":"Mattie D, Pe\u00f1a-Castillo L, Takahashi E, Levman J (2024) MRI diffusion connectomics-based characterization of progression in Alzheimer\u2019s disease. Appl Sci 14(16):7001","journal-title":"Appl Sci"},{"key":"5185_CR24","doi-asserted-by":"crossref","unstructured":"Mir M, Khosravani P, Ramezannezhad E, Saadabad FP, Falahati M, Ghanbarian M, et al (2025) Association between metabolomics findings and brain hypometabolism in mild Alzheimer\u2019s disease#. Curr Alzheimer Rese","DOI":"10.2174\/0115672050350196250110092338"},{"issue":"2","key":"5185_CR25","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1373\/clinchem.2004.039347","volume":"51","author":"A Olsson","year":"2005","unstructured":"Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B et al (2005) Simultaneous measurement of \u03b2-amyloid (1\u201342), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem 51(2):336\u201345","journal-title":"Clin Chem"},{"issue":"1","key":"5185_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1161\/01.STR.0000150668.58689.f2","volume":"36","author":"C DeCarli","year":"2005","unstructured":"DeCarli C, Fletcher E, Ramey V, Harvey D, Jagust WJ (2005) Anatomical mapping of white matter hyperintensities (wmh) exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke 36(1):50\u201355","journal-title":"Stroke"},{"issue":"6","key":"5185_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/01.rmr.0000245456.98029.a8","volume":"16","author":"M Yoshita","year":"2005","unstructured":"Yoshita M, Fletcher E, DeCarli C (2005) Current concepts of analysis of cerebral white matter hyperintensities on magnetic resonance imaging. Top Magn Reson Imaging 16(6):399\u2013407","journal-title":"Top Magn Reson Imaging"},{"issue":"5","key":"5185_CR28","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/00004728-200109000-00023","volume":"25","author":"P Kochunov","year":"2001","unstructured":"Kochunov P, Lancaster JL, Thompson P, Woods R, Mazziotta J, Hardies J et al (2001) Regional spatial normalization: toward an optimal target. J Comput Assist Tomogr 25(5):805\u2013816","journal-title":"J Comput Assist Tomogr"},{"issue":"2","key":"5185_CR29","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3233\/JAD-191005","volume":"73","author":"Y-L Wang","year":"2020","unstructured":"Wang Y-L, Chen W, Cai W-J, Hu H, Xu W, Wang Z-T et al (2020) Associations of white matter hyperintensities with cognitive decline: a longitudinal study. J Alzheimer\u2019s Dis 73(2):759\u2013768","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"3","key":"5185_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","volume":"11","author":"ND Prins","year":"2015","unstructured":"Prins ND, Scheltens P (2015) White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol 11(3):157\u2013165","journal-title":"Nat Rev Neurol"},{"key":"5185_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neurobiolaging.2020.03.008","volume":"91","author":"P Walsh","year":"2020","unstructured":"Walsh P, Sudre CH, Fiford CM, Ryan NS, Lashley T, Frost C et al (2020) CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer\u2019s disease. Neurobiol Aging 91:5\u201314","journal-title":"Neurobiol Aging"},{"issue":"6","key":"5185_CR32","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ana.24647","volume":"79","author":"S Lee","year":"2016","unstructured":"Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL et al (2016) White matter hyperintensities are a core feature of Alzheimer\u2019s disease: evidence from the dominantly inherited Alzheimer network. Ann Neurol 79(6):929\u2013939","journal-title":"Ann Neurol"}],"updated-by":[{"DOI":"10.1007\/s12035-025-05273-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000}}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05185-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05185-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05185-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:34:50Z","timestamp":1760074490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05185-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["5185"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05185-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to add the institutional author \"for the Alzheimer's Disease Neuroimaging Initiative\".","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12035-025-05273-x","URL":"https:\/\/doi.org\/10.1007\/s12035-025-05273-x","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used data from the ADNI database, which received prior ethical approval. All ethical considerations, including informed consent and data privacy, were managed by ADNI. As this study involved only secondary analysis of de-identified, publicly available data, no additional ethical approval was required. Therefore, declarations related to human ethics and consent to participate are not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}